3,288 followers
High bone turnover status as a risk factor in symptomatic hypocalcemia following denosumab treatment in osteoporosis patient without renal impairment, despite prophylactic vitamin D. Ishikawa K et al. Clin Interv Aging. 2018 Oct 8 https://t.co/yOz8Ir46fg